nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—SLC22A3—prostate cancer	0.0906	0.236	CbGaD
Nicotine—SLC22A1—prostate cancer	0.065	0.169	CbGaD
Nicotine—CYP2A6—prostate cancer	0.0508	0.132	CbGaD
Nicotine—CYP19A1—prostate cancer	0.0483	0.126	CbGaD
Nicotine—CYP2E1—prostate cancer	0.036	0.0937	CbGaD
Nicotine—CYP2C19—prostate cancer	0.0357	0.0928	CbGaD
Nicotine—CYP1A1—prostate cancer	0.0356	0.0924	CbGaD
Nicotine—CYP3A4—prostate cancer	0.0227	0.059	CbGaD
Nicotine—SLC22A3—Estradiol—prostate cancer	0.0202	0.0588	CbGbCtD
Nicotine—CYP1A1—Flutamide—prostate cancer	0.0196	0.0571	CbGbCtD
Nicotine—CYP1A1—Estrone—prostate cancer	0.0142	0.0413	CbGbCtD
Nicotine—CYP2C8—Nilutamide—prostate cancer	0.0136	0.0398	CbGbCtD
Nicotine—SLC22A2—Estradiol—prostate cancer	0.0119	0.0348	CbGbCtD
Nicotine—CYP2C19—Nilutamide—prostate cancer	0.0114	0.0334	CbGbCtD
Nicotine—CYP2C19—Bicalutamide—prostate cancer	0.0114	0.0334	CbGbCtD
Nicotine—CYP2C8—Abiraterone—prostate cancer	0.0113	0.033	CbGbCtD
Nicotine—CYP2E1—Estrone—prostate cancer	0.0109	0.0319	CbGbCtD
Nicotine—CYP2B6—Estrone—prostate cancer	0.0108	0.0315	CbGbCtD
Nicotine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0105	0.0307	CbGbCtD
Nicotine—SLC22A1—Estradiol—prostate cancer	0.0104	0.0303	CbGbCtD
Nicotine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00961	0.0281	CbGbCtD
Nicotine—CYP2C9—Nilutamide—prostate cancer	0.00951	0.0278	CbGbCtD
Nicotine—CYP2C9—Bicalutamide—prostate cancer	0.00951	0.0278	CbGbCtD
Nicotine—CYP2C19—Flutamide—prostate cancer	0.00948	0.0277	CbGbCtD
Nicotine—CYP1A2—Flutamide—prostate cancer	0.00874	0.0255	CbGbCtD
Nicotine—CYP2D6—Bicalutamide—prostate cancer	0.00869	0.0254	CbGbCtD
Nicotine—CYP2C8—Cabazitaxel—prostate cancer	0.00836	0.0244	CbGbCtD
Nicotine—CYP1A1—Estradiol—prostate cancer	0.00813	0.0237	CbGbCtD
Nicotine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00728	0.0213	CbGbCtD
Nicotine—CYP2D6—Abiraterone—prostate cancer	0.0072	0.021	CbGbCtD
Nicotine—CYP2E1—Mitoxantrone—prostate cancer	0.0065	0.019	CbGbCtD
Nicotine—CYP1A2—Estrone—prostate cancer	0.00632	0.0185	CbGbCtD
Nicotine—CYP2C9—Estrone—prostate cancer	0.0057	0.0166	CbGbCtD
Nicotine—CYP3A4—Bicalutamide—prostate cancer	0.00553	0.0161	CbGbCtD
Nicotine—CYP3A4—Estramustine—prostate cancer	0.00514	0.015	CbGbCtD
Nicotine—CYP2C8—Estradiol—prostate cancer	0.00469	0.0137	CbGbCtD
Nicotine—CYP3A4—Abiraterone—prostate cancer	0.00458	0.0134	CbGbCtD
Nicotine—CYP3A4—Flutamide—prostate cancer	0.00458	0.0134	CbGbCtD
Nicotine—CYP2C9—Capecitabine—prostate cancer	0.00432	0.0126	CbGbCtD
Nicotine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00414	0.0121	CbGbCtD
Nicotine—CYP2E1—Etoposide—prostate cancer	0.0041	0.012	CbGbCtD
Nicotine—CYP2C19—Estradiol—prostate cancer	0.00393	0.0115	CbGbCtD
Nicotine—CYP1A2—Estradiol—prostate cancer	0.00363	0.0106	CbGbCtD
Nicotine—CYP3A4—Cabazitaxel—prostate cancer	0.00339	0.00989	CbGbCtD
Nicotine—CYP2C19—Prednisone—prostate cancer	0.00338	0.00988	CbGbCtD
Nicotine—CYP3A4—Estrone—prostate cancer	0.00331	0.00967	CbGbCtD
Nicotine—CYP2C9—Estradiol—prostate cancer	0.00327	0.00955	CbGbCtD
Nicotine—CYP2C8—Etoposide—prostate cancer	0.00306	0.00894	CbGbCtD
Nicotine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00295	0.00862	CbGbCtD
Nicotine—CYP2B6—Doxorubicin—prostate cancer	0.00276	0.00805	CbGbCtD
Nicotine—CHRNA5—prostate gland—prostate cancer	0.00249	0.0667	CbGeAlD
Nicotine—CYP1A2—Etoposide—prostate cancer	0.00237	0.00692	CbGbCtD
Nicotine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00217	0.00633	CbGbCtD
Nicotine—CYP19A1—semen—prostate cancer	0.00215	0.0575	CbGeAlD
Nicotine—CYP3A4—Mitoxantrone—prostate cancer	0.00197	0.00575	CbGbCtD
Nicotine—CYP3A4—Estradiol—prostate cancer	0.0019	0.00555	CbGbCtD
Nicotine—CHRNA5—Fulvestrant—Estradiol—prostate cancer	0.00169	1	CbGdCrCtD
Nicotine—CYP3A4—Prednisone—prostate cancer	0.00164	0.00478	CbGbCtD
Nicotine—CYP2D6—Doxorubicin—prostate cancer	0.00133	0.00389	CbGbCtD
Nicotine—CYP3A4—Etoposide—prostate cancer	0.00124	0.00363	CbGbCtD
Nicotine—CYP2C19—urine—prostate cancer	0.00123	0.0329	CbGeAlD
Nicotine—CYP3A4—Docetaxel—prostate cancer	0.00114	0.00332	CbGbCtD
Nicotine—CHRNA5—testis—prostate cancer	0.0011	0.0294	CbGeAlD
Nicotine—CHRNB2—prostate gland—prostate cancer	0.00108	0.029	CbGeAlD
Nicotine—CHRNA3—prostate gland—prostate cancer	0.00105	0.0282	CbGeAlD
Nicotine—CYP1A2—urine—prostate cancer	0.001	0.0269	CbGeAlD
Nicotine—CHRNA2—prostate gland—prostate cancer	0.000977	0.0262	CbGeAlD
Nicotine—CYP2C9—urine—prostate cancer	0.000953	0.0255	CbGeAlD
Nicotine—CYP2E1—urine—prostate cancer	0.000903	0.0242	CbGeAlD
Nicotine—CYP3A4—Doxorubicin—prostate cancer	0.000847	0.00247	CbGbCtD
Nicotine—CHRNA5—lymph node—prostate cancer	0.000795	0.0213	CbGeAlD
Nicotine—CHRNB4—testis—prostate cancer	0.000755	0.0202	CbGeAlD
Nicotine—CYP3A4—urine—prostate cancer	0.000727	0.0195	CbGeAlD
Nicotine—CHRNB2—urethra—prostate cancer	0.000726	0.0194	CbGeAlD
Nicotine—CYP2D6—urine—prostate cancer	0.000715	0.0192	CbGeAlD
Nicotine—CYP2A6—prostate gland—prostate cancer	0.000686	0.0184	CbGeAlD
Nicotine—CHRNA10—testis—prostate cancer	0.000665	0.0178	CbGeAlD
Nicotine—SLC22A4—prostate gland—prostate cancer	0.000601	0.0161	CbGeAlD
Nicotine—CYP2A6—seminal vesicle—prostate cancer	0.00058	0.0156	CbGeAlD
Nicotine—CHRNB2—bone marrow—prostate cancer	0.000559	0.015	CbGeAlD
Nicotine—SLC22A2—renal system—prostate cancer	0.000552	0.0148	CbGeAlD
Nicotine—SLC22A3—prostate gland—prostate cancer	0.000547	0.0147	CbGeAlD
Nicotine—CYP19A1—prostate gland—prostate cancer	0.000538	0.0144	CbGeAlD
Nicotine—SLC22A4—seminal vesicle—prostate cancer	0.000509	0.0136	CbGeAlD
Nicotine—MAOB—prostate gland—prostate cancer	0.000506	0.0136	CbGeAlD
Nicotine—CHRNA10—lymph node—prostate cancer	0.000482	0.0129	CbGeAlD
Nicotine—CHRNB2—testis—prostate cancer	0.000478	0.0128	CbGeAlD
Nicotine—CHRNA7—renal system—prostate cancer	0.000468	0.0125	CbGeAlD
Nicotine—CHRNA3—testis—prostate cancer	0.000463	0.0124	CbGeAlD
Nicotine—SLC22A3—seminal vesicle—prostate cancer	0.000463	0.0124	CbGeAlD
Nicotine—MAOA—prostate gland—prostate cancer	0.000432	0.0116	CbGeAlD
Nicotine—MAOB—seminal vesicle—prostate cancer	0.000428	0.0115	CbGeAlD
Nicotine—SLC22A4—renal system—prostate cancer	0.00041	0.011	CbGeAlD
Nicotine—SLC22A5—prostate gland—prostate cancer	0.000398	0.0107	CbGeAlD
Nicotine—SLC22A1—renal system—prostate cancer	0.00039	0.0105	CbGeAlD
Nicotine—CHRFAM7A—testis—prostate cancer	0.000375	0.01	CbGeAlD
Nicotine—SLC22A3—renal system—prostate cancer	0.000373	0.00999	CbGeAlD
Nicotine—SLC22A3—urethra—prostate cancer	0.000366	0.00982	CbGeAlD
Nicotine—MAOA—seminal vesicle—prostate cancer	0.000365	0.00979	CbGeAlD
Nicotine—CHRNB2—lymph node—prostate cancer	0.000346	0.00927	CbGeAlD
Nicotine—MAOB—renal system—prostate cancer	0.000345	0.00925	CbGeAlD
Nicotine—MAOB—urethra—prostate cancer	0.000339	0.00908	CbGeAlD
Nicotine—SLC22A5—seminal vesicle—prostate cancer	0.000337	0.00902	CbGeAlD
Nicotine—CHRNA3—lymph node—prostate cancer	0.000336	0.00899	CbGeAlD
Nicotine—CYP2E1—prostate gland—prostate cancer	0.000324	0.00869	CbGeAlD
Nicotine—SLC22A4—bone marrow—prostate cancer	0.00031	0.0083	CbGeAlD
Nicotine—CHRNA7—testis—prostate cancer	0.000303	0.0081	CbGeAlD
Nicotine—MAOA—renal system—prostate cancer	0.000294	0.00789	CbGeAlD
Nicotine—MAOA—urethra—prostate cancer	0.000289	0.00775	CbGeAlD
Nicotine—CYP2E1—seminal vesicle—prostate cancer	0.000274	0.00735	CbGeAlD
Nicotine—SLC22A5—renal system—prostate cancer	0.000271	0.00727	CbGeAlD
Nicotine—SLC22A5—urethra—prostate cancer	0.000266	0.00714	CbGeAlD
Nicotine—CYP2C8—renal system—prostate cancer	0.000263	0.00703	CbGeAlD
Nicotine—CYP1A1—epithelium—prostate cancer	0.000261	0.007	CbGeAlD
Nicotine—CYP1A2—renal system—prostate cancer	0.000246	0.00658	CbGeAlD
Nicotine—CYP1A1—renal system—prostate cancer	0.000242	0.00649	CbGeAlD
Nicotine—SLC22A3—testis—prostate cancer	0.000241	0.00646	CbGeAlD
Nicotine—CYP1A1—urethra—prostate cancer	0.000238	0.00638	CbGeAlD
Nicotine—CYP19A1—testis—prostate cancer	0.000237	0.00635	CbGeAlD
Nicotine—CYP2B6—renal system—prostate cancer	0.000236	0.00631	CbGeAlD
Nicotine—MAOB—testis—prostate cancer	0.000223	0.00598	CbGeAlD
Nicotine—CYP2E1—renal system—prostate cancer	0.000221	0.00592	CbGeAlD
Nicotine—CYP2E1—urethra—prostate cancer	0.000217	0.00582	CbGeAlD
Nicotine—SLC22A4—lymph node—prostate cancer	0.000192	0.00514	CbGeAlD
Nicotine—MAOA—testis—prostate cancer	0.00019	0.0051	CbGeAlD
Nicotine—CYP3A4—renal system—prostate cancer	0.000178	0.00476	CbGeAlD
Nicotine—SLC22A5—testis—prostate cancer	0.000175	0.0047	CbGeAlD
Nicotine—CYP2D6—renal system—prostate cancer	0.000175	0.00469	CbGeAlD
Nicotine—SLC22A3—lymph node—prostate cancer	0.000175	0.00468	CbGeAlD
Nicotine—CYP19A1—lymph node—prostate cancer	0.000172	0.0046	CbGeAlD
Nicotine—CYP2C8—testis—prostate cancer	0.00017	0.00455	CbGeAlD
Nicotine—MAOB—lymph node—prostate cancer	0.000162	0.00433	CbGeAlD
Nicotine—CYP2B6—testis—prostate cancer	0.000152	0.00408	CbGeAlD
Nicotine—CYP2E1—testis—prostate cancer	0.000143	0.00383	CbGeAlD
Nicotine—MAOA—lymph node—prostate cancer	0.000138	0.0037	CbGeAlD
Nicotine—SLC22A5—lymph node—prostate cancer	0.000127	0.0034	CbGeAlD
Nicotine—CYP1A1—lymph node—prostate cancer	0.000114	0.00304	CbGeAlD
Nicotine—CYP2D6—testis—prostate cancer	0.000113	0.00303	CbGeAlD
Nicotine—Agitation—Prednisone—prostate cancer	3.21e-05	0.000261	CcSEcCtD
Nicotine—Oedema—Capecitabine—prostate cancer	3.2e-05	0.00026	CcSEcCtD
Nicotine—Angioedema—Prednisone—prostate cancer	3.2e-05	0.000259	CcSEcCtD
Nicotine—Urticaria—Etoposide—prostate cancer	3.16e-05	0.000257	CcSEcCtD
Nicotine—Stomatitis—Doxorubicin—prostate cancer	3.16e-05	0.000256	CcSEcCtD
Nicotine—Malaise—Prednisone—prostate cancer	3.15e-05	0.000256	CcSEcCtD
Nicotine—Shock—Capecitabine—prostate cancer	3.15e-05	0.000256	CcSEcCtD
Nicotine—Rhinitis—Epirubicin—prostate cancer	3.15e-05	0.000256	CcSEcCtD
Nicotine—Abdominal pain—Etoposide—prostate cancer	3.15e-05	0.000256	CcSEcCtD
Nicotine—Body temperature increased—Etoposide—prostate cancer	3.15e-05	0.000256	CcSEcCtD
Nicotine—Nervous system disorder—Capecitabine—prostate cancer	3.14e-05	0.000255	CcSEcCtD
Nicotine—Vertigo—Prednisone—prostate cancer	3.14e-05	0.000255	CcSEcCtD
Nicotine—Syncope—Prednisone—prostate cancer	3.14e-05	0.000255	CcSEcCtD
Nicotine—Tachycardia—Capecitabine—prostate cancer	3.13e-05	0.000254	CcSEcCtD
Nicotine—Hypoaesthesia—Epirubicin—prostate cancer	3.13e-05	0.000254	CcSEcCtD
Nicotine—Pharyngitis—Epirubicin—prostate cancer	3.12e-05	0.000253	CcSEcCtD
Nicotine—Hyperhidrosis—Capecitabine—prostate cancer	3.1e-05	0.000251	CcSEcCtD
Nicotine—Oedema peripheral—Epirubicin—prostate cancer	3.09e-05	0.000251	CcSEcCtD
Nicotine—Hypotension—Docetaxel—prostate cancer	3.09e-05	0.000251	CcSEcCtD
Nicotine—Loss of consciousness—Prednisone—prostate cancer	3.07e-05	0.00025	CcSEcCtD
Nicotine—Epistaxis—Doxorubicin—prostate cancer	3.05e-05	0.000248	CcSEcCtD
Nicotine—Nausea—Estradiol—prostate cancer	3.05e-05	0.000248	CcSEcCtD
Nicotine—Vomiting—Mitoxantrone—prostate cancer	3.04e-05	0.000247	CcSEcCtD
Nicotine—Sinusitis—Doxorubicin—prostate cancer	3.04e-05	0.000247	CcSEcCtD
Nicotine—Convulsion—Prednisone—prostate cancer	3.03e-05	0.000246	CcSEcCtD
Nicotine—Visual impairment—Epirubicin—prostate cancer	3.03e-05	0.000246	CcSEcCtD
Nicotine—Hypertension—Prednisone—prostate cancer	3.02e-05	0.000245	CcSEcCtD
Nicotine—Rash—Mitoxantrone—prostate cancer	3.02e-05	0.000245	CcSEcCtD
Nicotine—Dermatitis—Mitoxantrone—prostate cancer	3.02e-05	0.000245	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.01e-05	0.000245	CcSEcCtD
Nicotine—Headache—Mitoxantrone—prostate cancer	3e-05	0.000243	CcSEcCtD
Nicotine—Hypotension—Capecitabine—prostate cancer	2.99e-05	0.000243	CcSEcCtD
Nicotine—Insomnia—Docetaxel—prostate cancer	2.99e-05	0.000243	CcSEcCtD
Nicotine—Arthralgia—Prednisone—prostate cancer	2.98e-05	0.000242	CcSEcCtD
Nicotine—Myalgia—Prednisone—prostate cancer	2.98e-05	0.000242	CcSEcCtD
Nicotine—Paraesthesia—Docetaxel—prostate cancer	2.97e-05	0.000241	CcSEcCtD
Nicotine—Anxiety—Prednisone—prostate cancer	2.97e-05	0.000241	CcSEcCtD
Nicotine—Dyspnoea—Docetaxel—prostate cancer	2.95e-05	0.00024	CcSEcCtD
Nicotine—Somnolence—Docetaxel—prostate cancer	2.94e-05	0.000239	CcSEcCtD
Nicotine—Discomfort—Prednisone—prostate cancer	2.94e-05	0.000239	CcSEcCtD
Nicotine—Hypersensitivity—Etoposide—prostate cancer	2.93e-05	0.000238	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.92e-05	0.000237	CcSEcCtD
Nicotine—Cardiac disorder—Epirubicin—prostate cancer	2.92e-05	0.000237	CcSEcCtD
Nicotine—Flushing—Epirubicin—prostate cancer	2.92e-05	0.000237	CcSEcCtD
Nicotine—Rhinitis—Doxorubicin—prostate cancer	2.91e-05	0.000237	CcSEcCtD
Nicotine—Dyspepsia—Docetaxel—prostate cancer	2.91e-05	0.000237	CcSEcCtD
Nicotine—Insomnia—Capecitabine—prostate cancer	2.9e-05	0.000235	CcSEcCtD
Nicotine—Hypoaesthesia—Doxorubicin—prostate cancer	2.89e-05	0.000235	CcSEcCtD
Nicotine—Pharyngitis—Doxorubicin—prostate cancer	2.88e-05	0.000234	CcSEcCtD
Nicotine—Paraesthesia—Capecitabine—prostate cancer	2.88e-05	0.000234	CcSEcCtD
Nicotine—Oedema peripheral—Doxorubicin—prostate cancer	2.86e-05	0.000233	CcSEcCtD
Nicotine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.86e-05	0.000232	CcSEcCtD
Nicotine—Asthenia—Etoposide—prostate cancer	2.86e-05	0.000232	CcSEcCtD
Nicotine—Dyspnoea—Capecitabine—prostate cancer	2.86e-05	0.000232	CcSEcCtD
Nicotine—Anaphylactic shock—Prednisone—prostate cancer	2.85e-05	0.000232	CcSEcCtD
Nicotine—Oedema—Prednisone—prostate cancer	2.85e-05	0.000232	CcSEcCtD
Nicotine—Fatigue—Docetaxel—prostate cancer	2.85e-05	0.000232	CcSEcCtD
Nicotine—Nausea—Mitoxantrone—prostate cancer	2.84e-05	0.000231	CcSEcCtD
Nicotine—Immune system disorder—Epirubicin—prostate cancer	2.84e-05	0.00023	CcSEcCtD
Nicotine—Mediastinal disorder—Epirubicin—prostate cancer	2.83e-05	0.00023	CcSEcCtD
Nicotine—Pain—Docetaxel—prostate cancer	2.83e-05	0.00023	CcSEcCtD
Nicotine—Constipation—Docetaxel—prostate cancer	2.83e-05	0.00023	CcSEcCtD
Nicotine—Dyspepsia—Capecitabine—prostate cancer	2.82e-05	0.000229	CcSEcCtD
Nicotine—Pruritus—Etoposide—prostate cancer	2.82e-05	0.000229	CcSEcCtD
Nicotine—Shock—Prednisone—prostate cancer	2.81e-05	0.000228	CcSEcCtD
Nicotine—Arrhythmia—Epirubicin—prostate cancer	2.81e-05	0.000228	CcSEcCtD
Nicotine—Visual impairment—Doxorubicin—prostate cancer	2.8e-05	0.000227	CcSEcCtD
Nicotine—Nervous system disorder—Prednisone—prostate cancer	2.8e-05	0.000227	CcSEcCtD
Nicotine—Tachycardia—Prednisone—prostate cancer	2.79e-05	0.000226	CcSEcCtD
Nicotine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.77e-05	0.000225	CcSEcCtD
Nicotine—Fatigue—Capecitabine—prostate cancer	2.76e-05	0.000224	CcSEcCtD
Nicotine—Hyperhidrosis—Prednisone—prostate cancer	2.76e-05	0.000224	CcSEcCtD
Nicotine—Mental disorder—Epirubicin—prostate cancer	2.75e-05	0.000223	CcSEcCtD
Nicotine—Pain—Capecitabine—prostate cancer	2.74e-05	0.000222	CcSEcCtD
Nicotine—Constipation—Capecitabine—prostate cancer	2.74e-05	0.000222	CcSEcCtD
Nicotine—Erythema—Epirubicin—prostate cancer	2.73e-05	0.000222	CcSEcCtD
Nicotine—Feeling abnormal—Docetaxel—prostate cancer	2.73e-05	0.000221	CcSEcCtD
Nicotine—Diarrhoea—Etoposide—prostate cancer	2.72e-05	0.000221	CcSEcCtD
Nicotine—Gastrointestinal pain—Docetaxel—prostate cancer	2.71e-05	0.00022	CcSEcCtD
Nicotine—Cardiac disorder—Doxorubicin—prostate cancer	2.7e-05	0.000219	CcSEcCtD
Nicotine—Flushing—Doxorubicin—prostate cancer	2.7e-05	0.000219	CcSEcCtD
Nicotine—Flatulence—Epirubicin—prostate cancer	2.69e-05	0.000219	CcSEcCtD
Nicotine—Tension—Epirubicin—prostate cancer	2.68e-05	0.000218	CcSEcCtD
Nicotine—Dysgeusia—Epirubicin—prostate cancer	2.68e-05	0.000217	CcSEcCtD
Nicotine—Nervousness—Epirubicin—prostate cancer	2.66e-05	0.000216	CcSEcCtD
Nicotine—Back pain—Epirubicin—prostate cancer	2.65e-05	0.000215	CcSEcCtD
Nicotine—Feeling abnormal—Capecitabine—prostate cancer	2.64e-05	0.000214	CcSEcCtD
Nicotine—Dizziness—Etoposide—prostate cancer	2.63e-05	0.000214	CcSEcCtD
Nicotine—Muscle spasms—Epirubicin—prostate cancer	2.63e-05	0.000213	CcSEcCtD
Nicotine—Immune system disorder—Doxorubicin—prostate cancer	2.63e-05	0.000213	CcSEcCtD
Nicotine—Gastrointestinal pain—Capecitabine—prostate cancer	2.62e-05	0.000213	CcSEcCtD
Nicotine—Mediastinal disorder—Doxorubicin—prostate cancer	2.62e-05	0.000213	CcSEcCtD
Nicotine—Abdominal pain—Docetaxel—prostate cancer	2.62e-05	0.000212	CcSEcCtD
Nicotine—Body temperature increased—Docetaxel—prostate cancer	2.62e-05	0.000212	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.6e-05	0.000211	CcSEcCtD
Nicotine—Arrhythmia—Doxorubicin—prostate cancer	2.6e-05	0.000211	CcSEcCtD
Nicotine—Insomnia—Prednisone—prostate cancer	2.58e-05	0.00021	CcSEcCtD
Nicotine—Paraesthesia—Prednisone—prostate cancer	2.56e-05	0.000208	CcSEcCtD
Nicotine—Mental disorder—Doxorubicin—prostate cancer	2.55e-05	0.000207	CcSEcCtD
Nicotine—Urticaria—Capecitabine—prostate cancer	2.55e-05	0.000207	CcSEcCtD
Nicotine—Ill-defined disorder—Epirubicin—prostate cancer	2.54e-05	0.000206	CcSEcCtD
Nicotine—Body temperature increased—Capecitabine—prostate cancer	2.53e-05	0.000206	CcSEcCtD
Nicotine—Abdominal pain—Capecitabine—prostate cancer	2.53e-05	0.000206	CcSEcCtD
Nicotine—Vomiting—Etoposide—prostate cancer	2.53e-05	0.000206	CcSEcCtD
Nicotine—Erythema—Doxorubicin—prostate cancer	2.53e-05	0.000205	CcSEcCtD
Nicotine—Agitation—Epirubicin—prostate cancer	2.51e-05	0.000204	CcSEcCtD
Nicotine—Dyspepsia—Prednisone—prostate cancer	2.51e-05	0.000204	CcSEcCtD
Nicotine—Rash—Etoposide—prostate cancer	2.51e-05	0.000204	CcSEcCtD
Nicotine—Dermatitis—Etoposide—prostate cancer	2.51e-05	0.000204	CcSEcCtD
Nicotine—Headache—Etoposide—prostate cancer	2.49e-05	0.000203	CcSEcCtD
Nicotine—Flatulence—Doxorubicin—prostate cancer	2.49e-05	0.000202	CcSEcCtD
Nicotine—Tension—Doxorubicin—prostate cancer	2.48e-05	0.000202	CcSEcCtD
Nicotine—Dysgeusia—Doxorubicin—prostate cancer	2.48e-05	0.000201	CcSEcCtD
Nicotine—Malaise—Epirubicin—prostate cancer	2.47e-05	0.0002	CcSEcCtD
Nicotine—Fatigue—Prednisone—prostate cancer	2.46e-05	0.0002	CcSEcCtD
Nicotine—Nervousness—Doxorubicin—prostate cancer	2.46e-05	0.0002	CcSEcCtD
Nicotine—Vertigo—Epirubicin—prostate cancer	2.46e-05	0.0002	CcSEcCtD
Nicotine—Syncope—Epirubicin—prostate cancer	2.45e-05	0.000199	CcSEcCtD
Nicotine—Back pain—Doxorubicin—prostate cancer	2.45e-05	0.000199	CcSEcCtD
Nicotine—Constipation—Prednisone—prostate cancer	2.44e-05	0.000198	CcSEcCtD
Nicotine—Hypersensitivity—Docetaxel—prostate cancer	2.44e-05	0.000198	CcSEcCtD
Nicotine—Muscle spasms—Doxorubicin—prostate cancer	2.43e-05	0.000198	CcSEcCtD
Nicotine—Palpitations—Epirubicin—prostate cancer	2.42e-05	0.000196	CcSEcCtD
Nicotine—Loss of consciousness—Epirubicin—prostate cancer	2.4e-05	0.000195	CcSEcCtD
Nicotine—Cough—Epirubicin—prostate cancer	2.39e-05	0.000194	CcSEcCtD
Nicotine—Asthenia—Docetaxel—prostate cancer	2.37e-05	0.000193	CcSEcCtD
Nicotine—Convulsion—Epirubicin—prostate cancer	2.37e-05	0.000192	CcSEcCtD
Nicotine—Nausea—Etoposide—prostate cancer	2.37e-05	0.000192	CcSEcCtD
Nicotine—Hypertension—Epirubicin—prostate cancer	2.36e-05	0.000192	CcSEcCtD
Nicotine—Hypersensitivity—Capecitabine—prostate cancer	2.36e-05	0.000192	CcSEcCtD
Nicotine—Feeling abnormal—Prednisone—prostate cancer	2.35e-05	0.000191	CcSEcCtD
Nicotine—Ill-defined disorder—Doxorubicin—prostate cancer	2.35e-05	0.000191	CcSEcCtD
Nicotine—Pruritus—Docetaxel—prostate cancer	2.34e-05	0.00019	CcSEcCtD
Nicotine—Gastrointestinal pain—Prednisone—prostate cancer	2.33e-05	0.000189	CcSEcCtD
Nicotine—Myalgia—Epirubicin—prostate cancer	2.33e-05	0.000189	CcSEcCtD
Nicotine—Arthralgia—Epirubicin—prostate cancer	2.33e-05	0.000189	CcSEcCtD
Nicotine—Chest pain—Epirubicin—prostate cancer	2.33e-05	0.000189	CcSEcCtD
Nicotine—Agitation—Doxorubicin—prostate cancer	2.33e-05	0.000189	CcSEcCtD
Nicotine—Anxiety—Epirubicin—prostate cancer	2.32e-05	0.000188	CcSEcCtD
Nicotine—Discomfort—Epirubicin—prostate cancer	2.3e-05	0.000187	CcSEcCtD
Nicotine—Asthenia—Capecitabine—prostate cancer	2.3e-05	0.000187	CcSEcCtD
Nicotine—Malaise—Doxorubicin—prostate cancer	2.28e-05	0.000185	CcSEcCtD
Nicotine—Dry mouth—Epirubicin—prostate cancer	2.28e-05	0.000185	CcSEcCtD
Nicotine—Vertigo—Doxorubicin—prostate cancer	2.27e-05	0.000185	CcSEcCtD
Nicotine—Syncope—Doxorubicin—prostate cancer	2.27e-05	0.000184	CcSEcCtD
Nicotine—Urticaria—Prednisone—prostate cancer	2.27e-05	0.000184	CcSEcCtD
Nicotine—Pruritus—Capecitabine—prostate cancer	2.27e-05	0.000184	CcSEcCtD
Nicotine—Diarrhoea—Docetaxel—prostate cancer	2.26e-05	0.000184	CcSEcCtD
Nicotine—Abdominal pain—Prednisone—prostate cancer	2.26e-05	0.000183	CcSEcCtD
Nicotine—Body temperature increased—Prednisone—prostate cancer	2.26e-05	0.000183	CcSEcCtD
Nicotine—Confusional state—Epirubicin—prostate cancer	2.25e-05	0.000183	CcSEcCtD
Nicotine—Palpitations—Doxorubicin—prostate cancer	2.24e-05	0.000182	CcSEcCtD
Nicotine—Anaphylactic shock—Epirubicin—prostate cancer	2.23e-05	0.000181	CcSEcCtD
Nicotine—Oedema—Epirubicin—prostate cancer	2.23e-05	0.000181	CcSEcCtD
Nicotine—Loss of consciousness—Doxorubicin—prostate cancer	2.22e-05	0.000181	CcSEcCtD
Nicotine—Cough—Doxorubicin—prostate cancer	2.21e-05	0.000179	CcSEcCtD
Nicotine—Shock—Epirubicin—prostate cancer	2.2e-05	0.000178	CcSEcCtD
Nicotine—Convulsion—Doxorubicin—prostate cancer	2.19e-05	0.000178	CcSEcCtD
Nicotine—Diarrhoea—Capecitabine—prostate cancer	2.19e-05	0.000178	CcSEcCtD
Nicotine—Nervous system disorder—Epirubicin—prostate cancer	2.19e-05	0.000178	CcSEcCtD
Nicotine—Dizziness—Docetaxel—prostate cancer	2.19e-05	0.000178	CcSEcCtD
Nicotine—Hypertension—Doxorubicin—prostate cancer	2.18e-05	0.000177	CcSEcCtD
Nicotine—Tachycardia—Epirubicin—prostate cancer	2.18e-05	0.000177	CcSEcCtD
Nicotine—Hyperhidrosis—Epirubicin—prostate cancer	2.16e-05	0.000175	CcSEcCtD
Nicotine—Arthralgia—Doxorubicin—prostate cancer	2.15e-05	0.000175	CcSEcCtD
Nicotine—Myalgia—Doxorubicin—prostate cancer	2.15e-05	0.000175	CcSEcCtD
Nicotine—Chest pain—Doxorubicin—prostate cancer	2.15e-05	0.000175	CcSEcCtD
Nicotine—Anxiety—Doxorubicin—prostate cancer	2.15e-05	0.000174	CcSEcCtD
Nicotine—Discomfort—Doxorubicin—prostate cancer	2.13e-05	0.000173	CcSEcCtD
Nicotine—Dizziness—Capecitabine—prostate cancer	2.12e-05	0.000172	CcSEcCtD
Nicotine—Dry mouth—Doxorubicin—prostate cancer	2.11e-05	0.000171	CcSEcCtD
Nicotine—Vomiting—Docetaxel—prostate cancer	2.1e-05	0.000171	CcSEcCtD
Nicotine—Hypersensitivity—Prednisone—prostate cancer	2.1e-05	0.000171	CcSEcCtD
Nicotine—Rash—Docetaxel—prostate cancer	2.09e-05	0.000169	CcSEcCtD
Nicotine—Hypotension—Epirubicin—prostate cancer	2.09e-05	0.000169	CcSEcCtD
Nicotine—Dermatitis—Docetaxel—prostate cancer	2.08e-05	0.000169	CcSEcCtD
Nicotine—Confusional state—Doxorubicin—prostate cancer	2.08e-05	0.000169	CcSEcCtD
Nicotine—Headache—Docetaxel—prostate cancer	2.07e-05	0.000168	CcSEcCtD
Nicotine—Anaphylactic shock—Doxorubicin—prostate cancer	2.07e-05	0.000168	CcSEcCtD
Nicotine—Oedema—Doxorubicin—prostate cancer	2.07e-05	0.000168	CcSEcCtD
Nicotine—Asthenia—Prednisone—prostate cancer	2.05e-05	0.000166	CcSEcCtD
Nicotine—Vomiting—Capecitabine—prostate cancer	2.04e-05	0.000165	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.03e-05	0.000165	CcSEcCtD
Nicotine—Shock—Doxorubicin—prostate cancer	2.03e-05	0.000165	CcSEcCtD
Nicotine—Nervous system disorder—Doxorubicin—prostate cancer	2.03e-05	0.000164	CcSEcCtD
Nicotine—Rash—Capecitabine—prostate cancer	2.02e-05	0.000164	CcSEcCtD
Nicotine—Pruritus—Prednisone—prostate cancer	2.02e-05	0.000164	CcSEcCtD
Nicotine—Insomnia—Epirubicin—prostate cancer	2.02e-05	0.000164	CcSEcCtD
Nicotine—Dermatitis—Capecitabine—prostate cancer	2.02e-05	0.000164	CcSEcCtD
Nicotine—Tachycardia—Doxorubicin—prostate cancer	2.02e-05	0.000164	CcSEcCtD
Nicotine—Headache—Capecitabine—prostate cancer	2.01e-05	0.000163	CcSEcCtD
Nicotine—Paraesthesia—Epirubicin—prostate cancer	2e-05	0.000163	CcSEcCtD
Nicotine—Hyperhidrosis—Doxorubicin—prostate cancer	2e-05	0.000162	CcSEcCtD
Nicotine—Dyspnoea—Epirubicin—prostate cancer	1.99e-05	0.000162	CcSEcCtD
Nicotine—Somnolence—Epirubicin—prostate cancer	1.98e-05	0.000161	CcSEcCtD
Nicotine—Nausea—Docetaxel—prostate cancer	1.97e-05	0.00016	CcSEcCtD
Nicotine—Dyspepsia—Epirubicin—prostate cancer	1.96e-05	0.00016	CcSEcCtD
Nicotine—Diarrhoea—Prednisone—prostate cancer	1.95e-05	0.000159	CcSEcCtD
Nicotine—Hypotension—Doxorubicin—prostate cancer	1.93e-05	0.000157	CcSEcCtD
Nicotine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.93e-05	0.000156	CcSEcCtD
Nicotine—Fatigue—Epirubicin—prostate cancer	1.92e-05	0.000156	CcSEcCtD
Nicotine—Pain—Epirubicin—prostate cancer	1.91e-05	0.000155	CcSEcCtD
Nicotine—Constipation—Epirubicin—prostate cancer	1.91e-05	0.000155	CcSEcCtD
Nicotine—Nausea—Capecitabine—prostate cancer	1.9e-05	0.000155	CcSEcCtD
Nicotine—Dizziness—Prednisone—prostate cancer	1.89e-05	0.000153	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.88e-05	0.000153	CcSEcCtD
Nicotine—Insomnia—Doxorubicin—prostate cancer	1.87e-05	0.000152	CcSEcCtD
Nicotine—Paraesthesia—Doxorubicin—prostate cancer	1.85e-05	0.000151	CcSEcCtD
Nicotine—Dyspnoea—Doxorubicin—prostate cancer	1.84e-05	0.000149	CcSEcCtD
Nicotine—Feeling abnormal—Epirubicin—prostate cancer	1.84e-05	0.000149	CcSEcCtD
Nicotine—Somnolence—Doxorubicin—prostate cancer	1.84e-05	0.000149	CcSEcCtD
Nicotine—Gastrointestinal pain—Epirubicin—prostate cancer	1.83e-05	0.000148	CcSEcCtD
Nicotine—Dyspepsia—Doxorubicin—prostate cancer	1.82e-05	0.000148	CcSEcCtD
Nicotine—Vomiting—Prednisone—prostate cancer	1.81e-05	0.000147	CcSEcCtD
Nicotine—Rash—Prednisone—prostate cancer	1.8e-05	0.000146	CcSEcCtD
Nicotine—Dermatitis—Prednisone—prostate cancer	1.8e-05	0.000146	CcSEcCtD
Nicotine—Headache—Prednisone—prostate cancer	1.79e-05	0.000145	CcSEcCtD
Nicotine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.78e-05	0.000145	CcSEcCtD
Nicotine—Fatigue—Doxorubicin—prostate cancer	1.78e-05	0.000145	CcSEcCtD
Nicotine—Urticaria—Epirubicin—prostate cancer	1.77e-05	0.000144	CcSEcCtD
Nicotine—Pain—Doxorubicin—prostate cancer	1.77e-05	0.000143	CcSEcCtD
Nicotine—Constipation—Doxorubicin—prostate cancer	1.77e-05	0.000143	CcSEcCtD
Nicotine—Abdominal pain—Epirubicin—prostate cancer	1.76e-05	0.000143	CcSEcCtD
Nicotine—Body temperature increased—Epirubicin—prostate cancer	1.76e-05	0.000143	CcSEcCtD
Nicotine—Feeling abnormal—Doxorubicin—prostate cancer	1.7e-05	0.000138	CcSEcCtD
Nicotine—Nausea—Prednisone—prostate cancer	1.7e-05	0.000138	CcSEcCtD
Nicotine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.69e-05	0.000137	CcSEcCtD
Nicotine—Hypersensitivity—Epirubicin—prostate cancer	1.64e-05	0.000134	CcSEcCtD
Nicotine—Urticaria—Doxorubicin—prostate cancer	1.64e-05	0.000133	CcSEcCtD
Nicotine—Body temperature increased—Doxorubicin—prostate cancer	1.63e-05	0.000133	CcSEcCtD
Nicotine—Abdominal pain—Doxorubicin—prostate cancer	1.63e-05	0.000133	CcSEcCtD
Nicotine—Asthenia—Epirubicin—prostate cancer	1.6e-05	0.00013	CcSEcCtD
Nicotine—Pruritus—Epirubicin—prostate cancer	1.58e-05	0.000128	CcSEcCtD
Nicotine—Diarrhoea—Epirubicin—prostate cancer	1.53e-05	0.000124	CcSEcCtD
Nicotine—Hypersensitivity—Doxorubicin—prostate cancer	1.52e-05	0.000124	CcSEcCtD
Nicotine—Asthenia—Doxorubicin—prostate cancer	1.48e-05	0.00012	CcSEcCtD
Nicotine—Dizziness—Epirubicin—prostate cancer	1.48e-05	0.00012	CcSEcCtD
Nicotine—Pruritus—Doxorubicin—prostate cancer	1.46e-05	0.000119	CcSEcCtD
Nicotine—Vomiting—Epirubicin—prostate cancer	1.42e-05	0.000115	CcSEcCtD
Nicotine—Diarrhoea—Doxorubicin—prostate cancer	1.41e-05	0.000115	CcSEcCtD
Nicotine—Rash—Epirubicin—prostate cancer	1.41e-05	0.000114	CcSEcCtD
Nicotine—Dermatitis—Epirubicin—prostate cancer	1.41e-05	0.000114	CcSEcCtD
Nicotine—Headache—Epirubicin—prostate cancer	1.4e-05	0.000114	CcSEcCtD
Nicotine—Dizziness—Doxorubicin—prostate cancer	1.37e-05	0.000111	CcSEcCtD
Nicotine—Nausea—Epirubicin—prostate cancer	1.33e-05	0.000108	CcSEcCtD
Nicotine—Vomiting—Doxorubicin—prostate cancer	1.31e-05	0.000107	CcSEcCtD
Nicotine—Rash—Doxorubicin—prostate cancer	1.3e-05	0.000106	CcSEcCtD
Nicotine—Dermatitis—Doxorubicin—prostate cancer	1.3e-05	0.000106	CcSEcCtD
Nicotine—Headache—Doxorubicin—prostate cancer	1.29e-05	0.000105	CcSEcCtD
Nicotine—Nausea—Doxorubicin—prostate cancer	1.23e-05	9.96e-05	CcSEcCtD
Nicotine—CYP1A2—Metabolism—NCOA2—prostate cancer	8.86e-07	8.01e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—NOS3—prostate cancer	8.84e-07	8e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—LPL—prostate cancer	8.83e-07	7.99e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NCOA1—prostate cancer	8.81e-07	7.97e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—COMT—prostate cancer	8.78e-07	7.94e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTP1—prostate cancer	8.74e-07	7.9e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NCOA1—prostate cancer	8.74e-07	7.9e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CD—prostate cancer	8.73e-07	7.9e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.71e-07	7.88e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP19A1—prostate cancer	8.68e-07	7.86e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MTHFR—prostate cancer	8.67e-07	7.84e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CAV1—prostate cancer	8.66e-07	7.84e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP19A1—prostate cancer	8.61e-07	7.79e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ITPR1—prostate cancer	8.6e-07	7.78e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CD—prostate cancer	8.6e-07	7.78e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MED12—prostate cancer	8.57e-07	7.75e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP1A1—prostate cancer	8.53e-07	7.71e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PPARA—prostate cancer	8.51e-07	7.7e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GNG5—prostate cancer	8.5e-07	7.69e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CAV1—prostate cancer	8.48e-07	7.67e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ERCC2—prostate cancer	8.46e-07	7.65e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.45e-07	7.65e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SLC5A5—prostate cancer	8.45e-07	7.65e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—RXRA—prostate cancer	8.38e-07	7.58e-06	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTEN—prostate cancer	8.34e-07	7.54e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—RXRA—prostate cancer	8.31e-07	7.52e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP2E1—prostate cancer	8.25e-07	7.47e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—NOS3—prostate cancer	8.24e-07	7.46e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOA3—prostate cancer	8.19e-07	7.41e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NQO1—prostate cancer	8.16e-07	7.38e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CB—prostate cancer	8.16e-07	7.38e-06	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTEN—prostate cancer	8.13e-07	7.36e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TYMS—prostate cancer	8.12e-07	7.35e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NOS3—prostate cancer	8.12e-07	7.34e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—prostate cancer	8.09e-07	7.32e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.08e-07	7.31e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—COMT—prostate cancer	8.07e-07	7.3e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TH—prostate cancer	8.04e-07	7.28e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTP1—prostate cancer	8.04e-07	7.27e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTM1—prostate cancer	8.03e-07	7.26e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—COMT—prostate cancer	8e-07	7.24e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CAV1—prostate cancer	8e-07	7.24e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.99e-07	7.23e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTP1—prostate cancer	7.97e-07	7.21e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP3A4—prostate cancer	7.96e-07	7.2e-06	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—prostate cancer	7.95e-07	7.19e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MTHFR—prostate cancer	7.95e-07	7.19e-06	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CA—prostate cancer	7.93e-07	7.18e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.92e-07	7.16e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ITPR1—prostate cancer	7.91e-07	7.15e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CG—prostate cancer	7.89e-07	7.14e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—LPL—prostate cancer	7.88e-07	7.13e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ITPR1—prostate cancer	7.84e-07	7.09e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP1B1—prostate cancer	7.83e-07	7.08e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HPGDS—prostate cancer	7.81e-07	7.07e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PPARA—prostate cancer	7.8e-07	7.06e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.77e-07	7.03e-06	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—prostate cancer	7.76e-07	7.02e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CG—prostate cancer	7.73e-07	6.99e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.71e-07	6.97e-06	CbGpPWpGaD
Nicotine—MAOB—Metabolism—AKT1—prostate cancer	7.66e-07	6.93e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.64e-07	6.91e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP1A1—prostate cancer	7.61e-07	6.89e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CB—prostate cancer	7.61e-07	6.88e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ACHE—prostate cancer	7.58e-07	6.86e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTT1—prostate cancer	7.58e-07	6.86e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GGT1—prostate cancer	7.58e-07	6.86e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ERCC2—prostate cancer	7.55e-07	6.83e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—prostate cancer	7.54e-07	6.82e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.49e-07	6.78e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CB—prostate cancer	7.49e-07	6.78e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TYMS—prostate cancer	7.47e-07	6.76e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—INS—prostate cancer	7.47e-07	6.76e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NCOA1—prostate cancer	7.46e-07	6.75e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—prostate cancer	7.42e-07	6.72e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TYMS—prostate cancer	7.41e-07	6.7e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTM1—prostate cancer	7.38e-07	6.68e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP19A1—prostate cancer	7.36e-07	6.66e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CAV1—prostate cancer	7.33e-07	6.63e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTM1—prostate cancer	7.32e-07	6.62e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CREBBP—prostate cancer	7.31e-07	6.62e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—INS—prostate cancer	7.31e-07	6.62e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.29e-07	6.59e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CG—prostate cancer	7.29e-07	6.59e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PRKACB—prostate cancer	7.25e-07	6.56e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—LPL—prostate cancer	7.25e-07	6.56e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—LPL—prostate cancer	7.19e-07	6.5e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.17e-07	6.49e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CREBBP—prostate cancer	7.16e-07	6.48e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—RXRA—prostate cancer	7.1e-07	6.42e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MTHFR—prostate cancer	7.1e-07	6.42e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTEN—prostate cancer	7.05e-07	6.38e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.01e-07	6.34e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP1A1—prostate cancer	7e-07	6.33e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PPARA—prostate cancer	6.96e-07	6.3e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ERCC2—prostate cancer	6.94e-07	6.28e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.94e-07	6.28e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CD—prostate cancer	6.94e-07	6.27e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.91e-07	6.25e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—INS—prostate cancer	6.9e-07	6.24e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ERCC2—prostate cancer	6.88e-07	6.23e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—COMT—prostate cancer	6.84e-07	6.19e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOA2—prostate cancer	6.84e-07	6.19e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTP1—prostate cancer	6.81e-07	6.16e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CD—prostate cancer	6.79e-07	6.15e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CREBBP—prostate cancer	6.75e-07	6.11e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—prostate cancer	6.73e-07	6.08e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ITPR1—prostate cancer	6.7e-07	6.06e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CG—prostate cancer	6.68e-07	6.04e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.59e-07	5.96e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTEN—prostate cancer	6.57e-07	5.95e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NOS3—prostate cancer	6.55e-07	5.92e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CAV1—prostate cancer	6.54e-07	5.92e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MTHFR—prostate cancer	6.53e-07	5.9e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.52e-07	5.9e-06	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—AKT1—prostate cancer	6.48e-07	5.86e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTEN—prostate cancer	6.47e-07	5.86e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MTHFR—prostate cancer	6.47e-07	5.85e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NOS3—prostate cancer	6.41e-07	5.8e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CD—prostate cancer	6.4e-07	5.79e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PPARA—prostate cancer	6.4e-07	5.79e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.37e-07	5.76e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PPARA—prostate cancer	6.35e-07	5.74e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TYMS—prostate cancer	6.33e-07	5.73e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—INS—prostate cancer	6.32e-07	5.72e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NQO1—prostate cancer	6.3e-07	5.7e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—prostate cancer	6.27e-07	5.67e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTM1—prostate cancer	6.26e-07	5.66e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.25e-07	5.66e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TH—prostate cancer	6.21e-07	5.62e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CREBBP—prostate cancer	6.19e-07	5.6e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—prostate cancer	6.17e-07	5.59e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—LPL—prostate cancer	6.14e-07	5.56e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NOS3—prostate cancer	6.05e-07	5.47e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CB—prostate cancer	6.04e-07	5.47e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.04e-07	5.46e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CAV1—prostate cancer	6.02e-07	5.45e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—prostate cancer	5.99e-07	5.42e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CAV1—prostate cancer	5.97e-07	5.4e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CG—prostate cancer	5.96e-07	5.39e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.93e-07	5.37e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CB—prostate cancer	5.92e-07	5.36e-06	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CA—prostate cancer	5.88e-07	5.32e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ERCC2—prostate cancer	5.88e-07	5.32e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CD—prostate cancer	5.87e-07	5.31e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—prostate cancer	5.87e-07	5.31e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GGT1—prostate cancer	5.85e-07	5.29e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOA1—prostate cancer	5.76e-07	5.21e-06	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CA—prostate cancer	5.74e-07	5.19e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.7e-07	5.16e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.68e-07	5.14e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—INS—prostate cancer	5.64e-07	5.11e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CB—prostate cancer	5.58e-07	5.05e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NOS3—prostate cancer	5.54e-07	5.02e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—prostate cancer	5.53e-07	5e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MTHFR—prostate cancer	5.53e-07	5e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CREBBP—prostate cancer	5.53e-07	5e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CG—prostate cancer	5.48e-07	4.96e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—RXRA—prostate cancer	5.48e-07	4.96e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CG—prostate cancer	5.44e-07	4.92e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PPARA—prostate cancer	5.42e-07	4.91e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—COMT—prostate cancer	5.28e-07	4.78e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTP1—prostate cancer	5.25e-07	4.75e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CD—prostate cancer	5.24e-07	4.74e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTEN—prostate cancer	5.22e-07	4.73e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—INS—prostate cancer	5.19e-07	4.7e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ITPR1—prostate cancer	5.17e-07	4.68e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—INS—prostate cancer	5.15e-07	4.66e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.12e-07	4.63e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTEN—prostate cancer	5.12e-07	4.63e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CAV1—prostate cancer	5.1e-07	4.61e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CREBBP—prostate cancer	5.08e-07	4.6e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—prostate cancer	5.07e-07	4.59e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CREBBP—prostate cancer	5.04e-07	4.56e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—prostate cancer	4.98e-07	4.51e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CA—prostate cancer	4.98e-07	4.5e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NOS3—prostate cancer	4.95e-07	4.48e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TYMS—prostate cancer	4.88e-07	4.42e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—prostate cancer	4.88e-07	4.41e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.87e-07	4.41e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTM1—prostate cancer	4.83e-07	4.37e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTEN—prostate cancer	4.82e-07	4.36e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CD—prostate cancer	4.82e-07	4.36e-06	CbGpPWpGaD
Nicotine—MAOA—Metabolism—AKT1—prostate cancer	4.81e-07	4.35e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.78e-07	4.32e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—LPL—prostate cancer	4.74e-07	4.29e-06	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—AKT1—prostate cancer	4.69e-07	4.24e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CG—prostate cancer	4.65e-07	4.2e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CA—prostate cancer	4.64e-07	4.2e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—prostate cancer	4.6e-07	4.16e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.58e-07	4.14e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CB—prostate cancer	4.57e-07	4.13e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CA—prostate cancer	4.57e-07	4.13e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NOS3—prostate cancer	4.55e-07	4.12e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ERCC2—prostate cancer	4.54e-07	4.11e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—prostate cancer	4.53e-07	4.09e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NOS3—prostate cancer	4.51e-07	4.08e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTEN—prostate cancer	4.42e-07	4e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—INS—prostate cancer	4.4e-07	3.98e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CREBBP—prostate cancer	4.31e-07	3.9e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MTHFR—prostate cancer	4.27e-07	3.86e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—prostate cancer	4.22e-07	3.82e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.2e-07	3.8e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PPARA—prostate cancer	4.19e-07	3.79e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CB—prostate cancer	4.17e-07	3.77e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—prostate cancer	4.16e-07	3.77e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—prostate cancer	4.13e-07	3.73e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CD—prostate cancer	4.08e-07	3.69e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—AKT1—prostate cancer	4.06e-07	3.68e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTEN—prostate cancer	3.95e-07	3.57e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CAV1—prostate cancer	3.94e-07	3.56e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NOS3—prostate cancer	3.86e-07	3.49e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—AKT1—prostate cancer	3.79e-07	3.43e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—prostate cancer	3.76e-07	3.41e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—AKT1—prostate cancer	3.73e-07	3.38e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CA—prostate cancer	3.69e-07	3.33e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTEN—prostate cancer	3.63e-07	3.28e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CA—prostate cancer	3.61e-07	3.27e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTEN—prostate cancer	3.6e-07	3.26e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.58e-07	3.24e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.56e-07	3.22e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—prostate cancer	3.53e-07	3.19e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—prostate cancer	3.46e-07	3.13e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—prostate cancer	3.43e-07	3.11e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CA—prostate cancer	3.4e-07	3.08e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—INS—prostate cancer	3.39e-07	3.07e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.32e-07	3.01e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.15e-07	2.85e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.12e-07	2.82e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTEN—prostate cancer	3.08e-07	2.78e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AKT1—prostate cancer	3.01e-07	2.72e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NOS3—prostate cancer	2.98e-07	2.69e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AKT1—prostate cancer	2.95e-07	2.67e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—prostate cancer	2.93e-07	2.65e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.78e-07	2.52e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AKT1—prostate cancer	2.78e-07	2.51e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.75e-07	2.49e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.72e-07	2.46e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.56e-07	2.32e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKT1—prostate cancer	2.55e-07	2.31e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.54e-07	2.3e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTEN—prostate cancer	2.37e-07	2.15e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKT1—prostate cancer	2.27e-07	2.06e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—prostate cancer	2.26e-07	2.05e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.17e-07	1.96e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKT1—prostate cancer	2.09e-07	1.89e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKT1—prostate cancer	2.07e-07	1.88e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKT1—prostate cancer	1.77e-07	1.6e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.67e-07	1.51e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKT1—prostate cancer	1.37e-07	1.24e-06	CbGpPWpGaD
